Focal or arm-level Chr6q loss is frequent in human DLBCL, with several minimal commonly deleted regions, of which one affects PHIP. We therefore sought to functionally validate Phip using the CRISPR/Cas9-based approach described above. This evidence concerns the gene PHIP and diffuse large B-cell lymphoma.